Gemtuzumab ozogamicin滅髓瘤MylotargTM

main article: targeted therapy

常常做成Gemtuzumab ozogamicin-Calicheamicin conjugate的形式(antibody-drug conjugates抗體藥物複合體/單株抗體藥品接合物/單株抗體藥品偶聯物ADCs), (target: CD33)